TY - JOUR AU - Maurer, T. AU - Gschwend, J. E. AU - Rauscher, I. AU - Souvatzoglou, M. AU - Haller, B. AU - Weirich, G. PY - 2016 DA - 2016// TI - Diagnostic efficacy of (68)Gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer JO - J Urol VL - 195 UR - https://doi.org/10.1016/j.juro.2015.12.025 DO - 10.1016/j.juro.2015.12.025 ID - Maurer2016 ER - TY - JOUR AU - Hernandez, D. AU - Salas, D. AU - Giménez, D. AU - Buitrago, P. AU - Esquena, S. AU - Palou, J. PY - 2015 DA - 2015// TI - Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy JO - Radiat Oncol VL - 10 UR - https://doi.org/10.1186/s13014-015-0574-6 DO - 10.1186/s13014-015-0574-6 ID - Hernandez2015 ER - TY - JOUR AU - Morigi, J. J. AU - Stricker, P. D. AU - van Leeuwen, P. J. AU - Tang, R. AU - Ho, B. AU - Nguyen, Q. PY - 2015 DA - 2015// TI - Prospective comparison of 18F-Fluoromethylcholine versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy JO - JNM VL - 56 UR - https://doi.org/10.2967/jnumed.115.160382 DO - 10.2967/jnumed.115.160382 ID - Morigi2015 ER - TY - JOUR AU - Schiller, K. AU - Sauter, K. AU - Dewes, S. AU - Eiber, M. AU - Maurer, T. AU - Gschwend, J. PY - 2017 DA - 2017// TI - Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after (68)Ga-PSMA-PET imaging JO - EJNMMI VL - 44 ID - Schiller2017 ER - TY - STD TI - Sterzing F, Kratochwil C, Fiedler H, Katayama S, Habl G, Kopka K, et al. 68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients. EJNMMI. 2016;43:34. ID - ref5 ER - TY - STD TI - Afaq A, Alahmed S, Chen SH, Lengana T, Haroon A, Payne H, et al. (68)Ga-PSMA PET/CT impact on prostate cancer management. JNM. 2018;59(1):89–92. ID - ref6 ER - TY - JOUR AU - Habl, G. AU - Sauter, K. AU - Schiller, K. AU - Dewes, S. AU - Maurer, T. AU - Eiber, M. PY - 2017 DA - 2017// TI - (68) Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: individualized medicine or new standard in salvage treatment JO - Prostate VL - 77 UR - https://doi.org/10.1002/pros.23347 DO - 10.1002/pros.23347 ID - Habl2017 ER - TY - JOUR AU - Albisinni, S. AU - Artigas, C. AU - Aoun, F. AU - Biaou, I. AU - Grosman, J. AU - Gil, T. PY - 2017 DA - 2017// TI - Clinical impact of (68) Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach JO - BJU Int VL - 120 UR - https://doi.org/10.1111/bju.13739 DO - 10.1111/bju.13739 ID - Albisinni2017 ER - TY - JOUR AU - Bluemel, C. AU - Linke, F. AU - Herrmann, K. AU - Simunovic, I. AU - Eiber, M. AU - Kestler, C. PY - 2016 DA - 2016// TI - Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy JO - EJNMMI Res VL - 6 UR - https://doi.org/10.1186/s13550-016-0233-4 DO - 10.1186/s13550-016-0233-4 ID - Bluemel2016 ER - TY - JOUR AU - Shakespeare, T. P. PY - 2015 DA - 2015// TI - Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists JO - Radiat Oncol VL - 10 UR - https://doi.org/10.1186/s13014-015-0548-8 DO - 10.1186/s13014-015-0548-8 ID - Shakespeare2015 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Zechmann, C. AU - Malcher, A. AU - Eder, M. AU - Eisenhut, M. AU - Linhart, H. PY - 2014 DA - 2014// TI - Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer JO - EJNMMI VL - 41 ID - Afshar-Oromieh2014 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Avtzi, E. AU - Giesel, F. AU - Holland-Letz, T. AU - Linhart, H. AU - Eder, M. PY - 2015 DA - 2015// TI - The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer JO - EJNMMI VL - 42 ID - Afshar-Oromieh2015 ER - TY - JOUR AU - Eiber, M. AU - Maurer, T. AU - Souvatzoglou, M. AU - Beer, A. J. AU - Ruffani, A. AU - Haller, B. PY - 2015 DA - 2015// TI - Evaluation of hybrid 68Ga-PSMA-ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy JO - JNM VL - 56 UR - https://doi.org/10.2967/jnumed.115.154153 DO - 10.2967/jnumed.115.154153 ID - Eiber2015 ER - TY - JOUR AU - Giesel, F. AU - Fiedler, H. AU - Stefanova, M. AU - Sterzing, F. AU - Rius, M. AU - Kopka, K. PY - 2015 DA - 2015// TI - PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer JO - EJNMMI VL - 42 ID - Giesel2015 ER - TY - JOUR AU - van Leeuwen, P. J. AU - Stricker, P. AU - Hruby, G. AU - Kneebone, A. AU - Ting, F. AU - Thompson, B. PY - 2016 DA - 2016// TI - (68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment JO - BJU Int VL - 117 UR - https://doi.org/10.1111/bju.13397 DO - 10.1111/bju.13397 ID - van Leeuwen2016 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Holland-Letz, T. AU - Giesel, F. L. AU - Kratochwil, C. AU - Mier, W. AU - Haufe, S. PY - 2017 DA - 2017// TI - Diagnostic performance of (68)Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients JO - EJNMMI VL - 44 ID - Afshar-Oromieh2017 ER - TY - JOUR AU - Pisansky, T. M. AU - Agrawal, S. AU - Hamstra, D. A. AU - Koontz, B. F. AU - Liauw, S. L. AU - Efstathiou, J. A. PY - 2016 DA - 2016// TI - Salvage radiation therapy dose response for biochemical failure of prostate cancer after prostatectomy—a multi-institutional observational study JO - Int J Radiat Oncol Biol Phys VL - 96 UR - https://doi.org/10.1016/j.ijrobp.2016.08.043 DO - 10.1016/j.ijrobp.2016.08.043 ID - Pisansky2016 ER - TY - JOUR AU - Ghadjar, P. AU - Hayoz, S. AU - Bernhard, J. AU - Zwahlen, D. R. AU - Hölscher, T. AU - Gut, P. PY - 2015 DA - 2015// TI - Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10 JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.63.3529 DO - 10.1200/JCO.2015.63.3529 ID - Ghadjar2015 ER - TY - STD TI - Schiavina R, Ceci F, Romagnoli D, Uprimny C, Brunocilla E, Borghesi M, et al. 68Ga-PSMA-PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer. Clin Genitourin Cancer. 2015;13(6):e415–7. ID - ref19 ER - TY - STD TI - Siriwardana A, Thompson J, van Leeuwen PJ, Doig S, Kalsbeek A, Emmett L, et al. Initial multicentre experience of 68gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited. BJU Int. 2017;120(5):673–81. ID - ref20 ER - TY - JOUR AU - Maurer, T. AU - Weirich, G. AU - Schottelius, M. AU - Weineisen, M. AU - Frisch, B. AU - Okur, A. PY - 2015 DA - 2015// TI - Prostate-specific membrane antigen–radioguided surgery for metastatic lymph nodes in prostate cancer JO - Eur Urol VL - 68 UR - https://doi.org/10.1016/j.eururo.2015.04.034 DO - 10.1016/j.eururo.2015.04.034 ID - Maurer2015 ER - TY - JOUR AU - Zschaeck, S. AU - Wust, P. AU - Beck, M. AU - Wlodarczyk, W. AU - Kaul, D. AU - Rogasch, J. PY - 2017 DA - 2017// TI - Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients JO - Radiat Oncol VL - 12 UR - https://doi.org/10.1186/s13014-017-0877-x DO - 10.1186/s13014-017-0877-x ID - Zschaeck2017 ER - TY - JOUR AU - Emmett, L. AU - Van Leeuwen, P. AU - Nandurkar, R. AU - Scheltema, M. J. AU - Cusick, T. AU - Hruby, G. PY - 2017 DA - 2017// TI - Treatment outcomes from (68)GaPSMA PET CT informed salvage radiation treatment in men with rising PSA following radical prostatectomy: prognostic value of a negative PSMA PET JO - J Nucl Med VL - 58 UR - https://doi.org/10.2967/jnumed.117.196683 DO - 10.2967/jnumed.117.196683 ID - Emmett2017 ER - TY - JOUR AU - Henkenberens, C. AU - Klot, C. A. AU - Ross, T. L. PY - 2016 DA - 2016// TI - 68Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer: early efficacy after primary therapy JO - Strahlenther Onkol VL - 192 UR - https://doi.org/10.1007/s00066-016-0982-z DO - 10.1007/s00066-016-0982-z ID - Henkenberens2016 ER - TY - JOUR AU - Henkenberens, C. AU - Von Klot, C. A. AU - Ross, T. L. AU - Bengel, F. M. AU - Wester, H. -. J. AU - Hüper, K. PY - 2017 DA - 2017// TI - 68Ga-PSMA ligand PET/CT-based radiotherapy for lymph node relapse of prostate cancer after primary therapy delays initiation of systemic therapy JO - Anticancer Res VL - 37 UR - https://doi.org/10.21873/anticanres.11444 DO - 10.21873/anticanres.11444 ID - Henkenberens2017 ER - TY - JOUR AU - Habl, G. AU - Straube, C. AU - Schiller, K. AU - Duma, M. N. AU - Oechsner, M. AU - Kessel, K. A. PY - 2017 DA - 2017// TI - Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT) JO - BMC Cancer VL - 17 UR - https://doi.org/10.1186/s12885-017-3341-2 DO - 10.1186/s12885-017-3341-2 ID - Habl2017 ER - TY - JOUR AU - Pasqualetti, F. AU - Panichi, M. AU - Sainato, A. AU - Matteucci, F. AU - Galli, L. AU - Cocuzza, P. PY - 2016 DA - 2016// TI - [18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results JO - Radiat Oncol VL - 11 UR - https://doi.org/10.1186/s13014-016-0586-x DO - 10.1186/s13014-016-0586-x ID - Pasqualetti2016 ER - TY - JOUR PY - 2014 DA - 2014// TI - World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects JO - J Am Coll Dent VL - 81 ID - ref28 ER - TY - JOUR AU - Weineisen, M. AU - Simecek, J. AU - Schottelius, M. AU - Schwaiger, M. AU - Wester, H. -. J. PY - 2014 DA - 2014// TI - Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer JO - EJNMMI Res VL - 4 UR - https://doi.org/10.1186/s13550-014-0063-1 DO - 10.1186/s13550-014-0063-1 ID - Weineisen2014 ER - TY - JOUR AU - Fendler, W. P. AU - Eiber, M. AU - Beheshti, M. AU - Bomanji, J. AU - Ceci, F. AU - Cho, S. PY - 2017 DA - 2017// TI - 68Ga-PSMA PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 JO - EJNMMI VL - 44 ID - Fendler2017 ER - TY - STD TI - Perera M, Papa N, Christidis D, Wetherell D, Hofman MS, Murphy DG, et al. Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis. Eur Urol. 2016;70(6):926–37. ID - ref31 ER - TY - JOUR AU - Tendulkar, R. D. AU - Agrawal, S. AU - Gao, T. AU - Efstathiou, J. A. AU - Pisansky, T. M. AU - Michalski, J. M. PY - 2016 DA - 2016// TI - Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2016.67.9647 DO - 10.1200/JCO.2016.67.9647 ID - Tendulkar2016 ER - TY - JOUR AU - Ceci, F. AU - Uprimny, C. AU - Nilica, B. AU - Geraldo, L. AU - Kendler, D. AU - Kroiss, A. PY - 2015 DA - 2015// TI - (68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? JO - EJNMMI VL - 42 ID - Ceci2015 ER - TY - JOUR AU - Briganti, A. AU - Karnes, R. J. AU - Da Pozzo, L. F. AU - Cozzarini, C. AU - Capitanio, U. AU - Gallina, A. PY - 2011 DA - 2011// TI - Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis JO - Eur Urol VL - 59 UR - https://doi.org/10.1016/j.eururo.2011.02.024 DO - 10.1016/j.eururo.2011.02.024 ID - Briganti2011 ER - TY - JOUR AU - Abdollah, F. AU - Karnes, R. J. AU - Suardi, N. AU - Cozzarini, C. AU - Gandaglia, G. AU - Fossati, N. PY - 2014 DA - 2014// TI - Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.54.7893 DO - 10.1200/JCO.2013.54.7893 ID - Abdollah2014 ER - TY - STD TI - Bartkowiak D, Thamm R, Bottke D, Siegmann A, Böhmer D, Budach V, Wiegel T. Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival. Acta Oncol. 2018;57(3):362–67. ID - ref36 ER - TY - JOUR AU - van Leeuwen, P. J. AU - Emmett, L. AU - Ho, B. AU - Delprado, W. AU - Ting, F. AU - Nguyen, Q. AU - Stricker, P. D. PY - 2017 DA - 2017// TI - Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer JO - BJU Int VL - 119 UR - https://doi.org/10.1111/bju.13540 DO - 10.1111/bju.13540 ID - van Leeuwen2017 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Sattler, L. P. AU - Mier, W. AU - Hadaschik, B. A. AU - Debus, J. AU - Holland-Letz, T. PY - 2017 DA - 2017// TI - The clinical impact of additional late PET/CT imaging with 68Ga-PSMA-11 (HBED-CC) in the diagnosis of prostate cancer JO - JNM VL - 58 UR - https://doi.org/10.2967/jnumed.116.183483 DO - 10.2967/jnumed.116.183483 ID - Afshar-Oromieh2017 ER - TY - JOUR AU - Derlin, T. AU - Weiberg, D. AU - von Klot, C. AU - Wester, H. -. J. AU - Henkenberens, C. PY - 2016 DA - 2016// TI - 68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging JO - Eur Radiol VL - 26 UR - https://doi.org/10.1007/s00330-016-4308-4 DO - 10.1007/s00330-016-4308-4 ID - Derlin2016 ER - TY - JOUR AU - Pfister, D. AU - Bolla, M. AU - Briganti, A. AU - Carroll, P. AU - Cozzarini, C. AU - Joniau, S. PY - 2014 DA - 2014// TI - Early salvage radiotherapy following radical prostatectomy JO - Eur Urol VL - 65 UR - https://doi.org/10.1016/j.eururo.2013.08.013 DO - 10.1016/j.eururo.2013.08.013 ID - Pfister2014 ER - TY - JOUR AU - Taguchi, S. AU - Shiraishi, K. AU - Fukuhara, H. AU - Nakagawa, K. AU - Morikawa, T. AU - Naito, A. PY - 2016 DA - 2016// TI - Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial? JO - Radiat Oncol VL - 11 UR - https://doi.org/10.1186/s13014-016-0671-1 DO - 10.1186/s13014-016-0671-1 ID - Taguchi2016 ER -